Highlights from SUO 2016 Annual Meeting

Viewing 1-20 of 57 articles

SUO 2016: Immunotherapy for Prostate Cancer: What is the Way Forward? - Session Highlights

SUO 2016: State-of-the-Art Lecture: Advances in Management in of Metastatic RCC - Session Highlights

SUO 2016: SLCO2B1: Biology & Therapeutic Implications - Session Highlights

SUO 2016: Oral Abstract – Lymph node yield as a predictor of overall survival following regional lymphadenectomy for penile cancer - Session Highlights

SUO 2016: Potential Therapeutic approaches to neuroendocrine prostate cancer - Session Highlights

SUO 2016: EAU Lecture: ProtecT trial - Session Highlights

SUO 2016: Targeting DNA repair pathways in prostate cancer - Session Highlights

SUO 2016: Mechanisms of Resistance to AR: AR Variants and GR - Session Highlights

SUO 2016: Novel predictive biomarkers for benefit of chemotherapy focusing on ERCC2 and other platinum sensitivity biomarkers - Session Highlights

SUO 2016: Novel predictive biomarkers for benefit of immune checkpoint blockade - Session Highlights

SUO 2016: Prevalence and prognostic significance of circulating tumor cells in clinically localized prostate cancer - Session Highlights

SUO 2016: Prospective multicenter comparison of open and robotic radical prostatectomy: the Prost-QA/RP2 consortium - Session Highlights

SUO 2016: Definite Treatment of Bladder Cancer in Octogenarians: Balancing Increased Perioperative Mortality with Superior Overall Survival - Poster Session Highlights

SUO 2016: Absence of Tumor on Repeat TURBT does not Predict Final Pathologic T0 Stage in Muscle Invasive Bladder Cancer Treated with Radical Cystectomy - Poster Session Highlights

SUO 2016: Panel on Surgical Management for Advanced Kidney Cancer: Controversies in Case Management - Session Highlights

SUO 2016: Therapeutic Drug Trials and Targeted Therapies in Kidney Cancer: Q&A Session - Session Highlights

SUO 2016: Targeted Therapies and Personalized Medicine in Kidney Cancer - Session Highlights

SUO 2016: Therapeutic drug trials in kidney cancer in the immune-oncology era: Update on Current Status and Rationale for Combination Trials - Session Highlights

SUO 2016: Evidence for colon cancer surveillance after resection and implications for urologic oncology - Session Highlights

SUO 2016: Competing trade-offs for kidney cancer surveillance - Session Highlights

1
2
3